期刊文献+

膀胱癌肿瘤免疫研究的现状与展望 被引量:3

Current status and prospects of immuno-oncology research in bladder cancer
原文传递
导出
摘要 在我国,膀胱癌是泌尿系统最常见的恶性肿瘤。肿瘤免疫在膀胱癌的发生、进展、治疗和治疗抵抗中发挥了重要作用。近年来,膀胱癌免疫微环境、免疫学诊断和免疫治疗的相关研究取得了长足进展。本文将从这3个方面对膀胱癌肿瘤免疫研究的现状进行综述。 Bladder cancer is the most common malignant tumor of urinary system in China.The immuno-oncology plays an important role in the occurrence,progression,treatment and therapy-resistance of bladder cancer.In recent years,great progress has been made in the research fields of immune microenvironment,immunological diagnosis and immunotherapy of bladder cancer.We will review the current status of immuno-oncology research in bladder cancer from above three aspects.
作者 胡恒龙 王少刚 Hu Henglong;Wang Shaogang(Deparment of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2020年第8期1389-1393,共5页 Chinese Journal of Experimental Surgery
关键词 膀胱癌 免疫微环境 诊断 免疫治疗 Bladder cancer Immunological microenvironment Diagnosis Immunotherapy
  • 相关文献

参考文献3

二级参考文献38

  • 1Siegel RL, Miller KD ,Jemal A. Cancer statistics 2015 [ J]. CA Cancer J Clin,2015,65 (1):5-29.
  • 2Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer[ J ]. Eur Uro1,2013,63 (2) :234-241.
  • 3Li N, Yang L, Zhang Y, et al. Human papillomavirus infection and bladder cancer risk : a meta-analysis [ J ]. J Infect Dis, 2011,204 ( 2 ) : 217-223.
  • 4Montella M, Di Maso M, Crispo A, et al. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study [ J ]. BMC Cancer,2015,15:720.
  • 5Nielsen ME, Smith AB, Meyer AM, et al. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States : 1988 to 2006 [ J ]. Cancer,2014,120 ( 1 ) :86-95.
  • 6Babjuk M, Burger M ,Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder:update 2013 [ J]. Eur Urol,2013,64(4) :639-653.
  • 7Gui Y, Guo G, Huang Y, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder [ J ]. Nat Genet,2011,43 ( 9 ) : 875-878.
  • 8Wu S,Yang Z, Ye R, et al. Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing[ J ]. Oncotarget,2016,7(3) :2629-2645.
  • 9Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma [ J ]. Nature, 2014, 507 ( 7492 ) :315-322.
  • 10Damrauer JS, Hoadley KA, Chism DD, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology[J]. Proc Natl Acad Sci U S A,2014,111(8) :3110-3115.

共引文献43

同被引文献28

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部